Latest filing published 04 Mar 2025 for Abbott Laboratories, €1.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Hubert l. Allen in Abbott Laboratories, where the filings describe the role as chief executive. The record holds 10 filings, for trades running from 18 February 2022 to 28 February 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 4 March 2025, reports a share grant of €1.1M in Abbott Laboratories. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations